ANAL FISSURE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Anal Fissure Treatment Market, By Treatment Type (Laxatives, Topical Nitrates, Calcium Channel Blockers, Stool Softeners, Surgery, Others), By Route of Administration (Oral, Topical, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Anal Fissure Treatment Market- Recent Developments

New Product Launches

On July 4, 2023, Acrux Limited, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had accepted Acrux’s application for a generic version (Abbreviated New Drug Application or ‘ANDA’) of Nitroglycerin Ointment, 0.4% for review. Nitroglycerin Ointment, 0.4% is used to treat moderate to severe pain associated with chronic anal fissure.

Acquisition and Partnerships

In May 8, 2020, AbbVie, a pharmaceutical company acquired Allergan in a US$ 63 billion deal, gaining access to Allergan’s leading gastroenterology portfolio